ACTG A5401 Protocol PF Fund

Project: Research project

Project Details


A5401 is a master protocol for a series of monoclonal antibodies that will be investigated in Phase 2 and 3 studies. We indicated a plan to enroll 10 participants in the first study.
Effective start/end date6/1/2011/30/20


  • University of California at Los Angeles (A5401//3UM1AI068636-14S2)
  • National Institute of Allergy and Infectious Diseases (A5401//3UM1AI068636-14S2)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.